fibrinogen has been researched along with Patent Foramen Ovale in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meus, R; Sobczyk, D; Son, M; Undas, A | 1 |
Pieculewicz, M; Podolec, P; Stepien, E; Undas, A; Wypasek, E | 1 |
2 other study(ies) available for fibrinogen and Patent Foramen Ovale
Article | Year |
---|---|
Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
Topics: Adult; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Foramen Ovale, Patent; Heart Diseases; Humans; Ischemic Attack, Transient; Male; Middle Aged; Migraine Disorders; Platelet Count; Smoking; Stroke Volume; Thrombin; Thrombophilia; Thrombosis | 2016 |
Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale.
Topics: Adult; Amino Acid Substitution; Case-Control Studies; Factor V; Factor XIII; Female; Fibrinogen; Foramen Ovale, Patent; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Prothrombin; Stroke | 2009 |